ÅǸ޴º
¹øÈ£ | ±¸ºÐ | Á¦¸ñ |
---|---|---|
172 | (±¹¿Ü)SCIE | The Prognosis and Oncological Predictor of Urachal Carcinoma of the Bladder: A Large Scale Multicenter Cohort Study Analyzed 203 Patients With Long Term Follow-Up |
171 | (±¹³»)SCI | Korean Version of the Patient Perception of Study Medication Questionnaire: Translation and Linguistic Validation |
170 | (±¹¿Ü)SCI | Development and validation of the Stent Tracking Algorithm Registry (STAR) for monitoring and retrieving forgotten ureteral stents |
169 | (±¹¿Ü)SCIE | "Current Status and Future Perspectives of Androgen Receptor Inhibition Therapy for Prostate Cancer: A Comprehensive Review" |
168 | (±¹¿Ü)SCIE | "Chimeric Antigen Receptor-Engineered T Cell Therapy for the Management of Patients with Metastatic Prostate Cancer: A Comprehensive Review" |
167 | (±¹¿Ü)SCIE | Feasibility and early toxicity of focal or partial brachytherapy in prostate cancer patients |
166 | (±¹¿Ü)SCIE | Patient-Derived, Drug-Resistant Colon Cancer Cells Evade Chemotherapeutic Drug Effects via the Induction of Epithelial-Mesenchymal Transition-Mediated Angiogenesis |
165 | (±¹¿Ü)SCIE | The role of Ureaplasmaparvumserovar-3 or serovar-14 infection in female patients with chronic micturition urethral pain and recurrent microscopic hematuria |
164 | (±¹¿Ü)SCIE | "Current Status and Future Perspectives of Checkpoint Inhibitor Immunotherapy for Prostate Cancer: A Comprehensive Review" |
163 | (±¹¿Ü)SCIE | "Pathophysiology of Bone Loss in Patients with Prostate Cancer Receiving Androgen-Deprivation Therapy and Lifestyle Modifications for the Management of Bone Health: A Comprehensive Review" |
Copyright ¨Ï chamc, All rights reserved.